Cambridge Investment Research Advisors, Inc. Insulet Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Insulet Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 4,031 shares of PODD stock, worth $871,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,031
Previous 4,266
5.51%
Holding current value
$871,139
Previous $731,000
11.22%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PODD
# of Institutions
659Shares Held
63.5MCall Options Held
385KPut Options Held
773K-
Vanguard Group Inc Valley Forge, PA8.4MShares$1.82 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.55 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.31 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.86MShares$618 Million0.03% of portfolio
-
Baillie Gifford & CO1.89MShares$408 Million0.3% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $15B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...